Zimmer Biomet launches foot, ankle trauma systems
October 9, 2025
Zimmer Biomet (NYSE: ZBH)+
announced that it launched two new solutions for complex foot and ankle trauma.
Zimmer Biomet (NYSE: ZBH)+
announced that it launched two new solutions for complex foot and ankle trauma.
JERSEY CITY, N.J. and OR YEHUDA, Israel, Oct. 8, 2025 /PRNewswire/ — Synchrony Medical, a medical technology company dedicated to transforming respiratory care, announced today the launch of its LibAirty™ Airway Clearance System in the United States. The launch marks an important step forward for people living with chronic lung disease, providing access to advanced at-home therapy designed to improve daily breathing, reduce exacerbations and hospitalizations, and enhance quality of life.
Remedy Robotics announced that it debuted the N1 system, a remotely operable endovascular surgical robotic system.
Medtronic (NYSE: MDT)+
today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.
Medtronic (NYSE: MDT)+
announced today that it kicked off the European launch of its VitalFlow one-system ECMO solution.
NEWPORT BEACH, Calif., Oct. 3, 2025 /PRNewswire/ — Gnosis for Her, a mobile breast health initiative redefining comfort and access in women’s breast imaging, made its national debut this past weekend at Susan G. Komen’s More Than Pink Walk at Fashion Island. More than 6,000 breast cancer survivors, loved ones, advocates, and supporters had the opportunity to see the Mobile Care Unit up close, tour inside, and speak with the expert team behind the service.
Aspivix, a FemTech company specialising in the modernisation of gynaecological care, has announced the official launch of its breakthrough device, carevix, now available to healthcare professionals in Southern California and New York State.
Olympus announced today that it launched its Olysense platform with Caddie medical device software for early colorectal polyp detection.
iAmbientHealth tracks vital signs such as heart rate, respiration, movement, and bed exit, leveraging radar technology.
Medtronic (NYSE: MDT)+
today reported the first patient treated with its Altaviva neuromodulation device for urge urinary incontinence.